Versatility of Aminoglycosides and Prospects for Their Future

SUMMARY Aminoglycoside antibiotics have had a major impact on our ability to treat bacterial infections for the past half century. Whereas the interest in these versatile antibiotics continues to be high, their clinical utility has been compromised by widespread instances of resistance. The multitude of mechanisms of resistance is disconcerting but also illuminates how nature can manifest resistance when bacteria are confronted by antibiotics. This article reviews the most recent knowledge about the mechanisms of aminoglycoside action and the mechanisms of resistance to these antibiotics.

[1]  C. Thompson,et al.  Nucleotide sequence of a streptomycete aminoglycoside phosphotransferase gene and its relationship to phosphotransferases encoded by resistance plasmids. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[2]  D. Mazel,et al.  Antibiotic Resistance in the ECOR Collection: Integrons and Identification of a Novel aad Gene , 2000, Antimicrobial Agents and Chemotherapy.

[3]  P. Kuhnert,et al.  Molecular epidemiology and genetic linkage of macrolide and aminoglycoside resistance in Staphylococcus intermedius of canine origin. , 2001, Veterinary microbiology.

[4]  F. Kayser,et al.  Purification and characterization of an aminoglycoside inactivating enzyme from Staphylococcus epidermidis FK109 that nucleotidylates the 4'- and 4''-hydroxyl groups of the aminoglycoside antibiotics. , 1978, The Journal of antibiotics.

[5]  C. A. Smith,et al.  Characterization of transferable plasmids from Shigella flexneri 2a that confer resistance to trimethoprim, streptomycin, and sulfonamides. , 1986, Plasmid.

[6]  E Westhof,et al.  Crystal structure of paromomycin docked into the eubacterial ribosomal decoding A site. , 2001, Structure.

[7]  E. Eber,et al.  Effects of inhaled gentamicin prophylaxis on acquisition of Pseudomonas aeruginosa in children with cystic fibrosis: A pilot study * , 2002, Pediatric pulmonology.

[8]  C. Bertozzi,et al.  Glycochemistry: Principles: Synthesis, and Applications , 2001 .

[9]  R. Moellering.  The enterococcus: a classic example of the impact of antimicrobial resistance on therapeutic options , 1991 .

[10]  R. Hall,et al.  New mobile gene cassettes containing an aminoglycoside resistance gene, aacA7, and a chloramphenicol resistance gene, catB3, in an integron in pBWH301 , 1995, Antimicrobial agents and chemotherapy.

[11]  M. Inoue,et al.  Nationwide investigation in Japan on the efficacy of arbekacin in methicillin-resistant Staphylococcus aureus infections. , 1994, Drugs under experimental and clinical research.

[12]  S. Lory,et al.  Complete genome sequence of Pseudomonas aeruginosa PAO 1 , an opportunistic pathogen , 2000 .

[13]  T. Beveridge,et al.  Gentamicin interaction with Pseudomonas aeruginosa cell envelope , 1986, Antimicrobial Agents and Chemotherapy.

[14]  R. Jacobs,et al.  Streptomycin and alternative agents for the treatment of tularemia: review of the literature. , 1994, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[15]  D. Daigle,et al.  Inhibition of Aminoglycoside Antibiotic Resistance Enzymes by Protein Kinase Inhibitors* , 1997, The Journal of Biological Chemistry.

[16]  P. Visca,et al.  Class 1 Integron-Borne Multiple-Antibiotic Resistance Carried by IncFI and IncL/M Plasmids in Salmonella enterica Serotype Typhimurium , 1998, Antimicrobial Agents and Chemotherapy.

[17]  P. Fey,et al.  Characterization of Plasmids Carrying CMY-2 from Expanded-Spectrum Cephalosporin-Resistant Salmonella Strains Isolated in the United States between 1996 and 1998 , 2002, Antimicrobial Agents and Chemotherapy.

[18]  R. Schiffelers,et al.  Liposome-encapsulated aminoglycosides in pre-clinical and clinical studies. , 2001, The Journal of antimicrobial chemotherapy.

[19]  P. Courvalin,et al.  Nucleotide sequence of Acinetobacter baumannii aphA‐6 gene: evolutionary and functional implications of sequence homologies with nucleotide‐binding proteins, kinases and other aminoglycoside‐modifying enzymes , 1988, Molecular microbiology.

[20]  J. Puglisi,et al.  Binding of neomycin-class aminoglycoside antibiotics to the A-site of 16 S rRNA. , 1998, Journal of molecular biology.

[21]  M. Pátek,et al.  An integron of class 1 is present on the plasmid pCG4 from gram-positive bacterium Corynebacterium glutamicum. , 1998, FEMS microbiology letters.

[22]  P. Rather,et al.  Molecular genetics of aminoglycoside resistance genes and familial relationships of the aminoglycoside-modifying enzymes. , 1993, Microbiological reviews.

[23]  P. Courvalin,et al.  Characterization of the chromosomal aac(6')-Ij gene of Acinetobacter sp. 13 and the aac(6')-Ih plasmid gene of Acinetobacter baumannii , 1994, Antimicrobial Agents and Chemotherapy.

[24]  B. Reiss,et al.  Nucleotide sequence and exact localization of the neomycin phosphotransferase gene from transposon Tn5. , 1982, Gene.

[25]  G. Archer,et al.  The Staphylococci in Human Disease , 1996 .

[26]  C. Wa,et al.  Killing and regrowth of bacteria in vitro: a review. , 1990 .

[27]  N. Cianciotto,et al.  Isolation of a gene encoding a novel spectinomycin phosphotransferase from Legionella pneumophila , 1997, Antimicrobial agents and chemotherapy.

[28]  R. Moellering.  In Vitro Antibacterial Activity of the Aminoglycoside Antibiotics , 1983 .

[29]  T. Imanaka,et al.  Complete nucleotide sequences of Bacillus plasmids pUB110dB, pRBH1 and its copy mutants , 2004, Molecular and General Genetics MGG.

[30]  S. Projan,et al.  New (and not so new) antibacterial targets - from where and when will the novel drugs come? , 2002, Current opinion in pharmacology.

[31]  R. Perry,et al.  Yersinia pestis--etiologic agent of plague , 1997, Clinical microbiology reviews.

[32]  V. Ramakrishnan,et al.  Recognition of Cognate Transfer RNA by the 30S Ribosomal Subunit , 2001, Science.

[33]  C. Kurland,et al.  Codon‐specific missense errors in vivo. , 1983, The EMBO journal.

[34]  R. Wagner,et al.  E. coli ribosomes with a C912 to U base change in the 16S rRNA are streptomycin resistant. , 1986, The EMBO journal.

[35]  Properties of a Bifunctional Bacterial Antibiotic Resistance Enzyme That Catalyzes ATP-Dependent 2‘‘-Phosphorylation and Acetyl-CoA-Dependent 6‘-Acetylation of Aminoglycosides , 1997 .

[36]  J. Klastersky,et al.  Susceptibility of "Pseudomonas aeruginosa" to combinations of antibiotics. , 1972, Pathologie-biologie.

[37]  Ulrich Stelzl,et al.  Protein synthesis at atomic resolution: mechanistics of translation in the light of highly resolved structures for the ribosome. , 2002, Current protein & peptide science.

[38]  M. Barclay,et al.  Once Daily Aminoglycoside Therapy , 1999, Clinical pharmacokinetics.

[39]  G. Rossolini,et al.  In70 of Plasmid pAX22, ablaVIM-1-Containing Integron Carrying a New Aminoglycoside Phosphotransferase Gene Cassette , 2001, Antimicrobial Agents and Chemotherapy.

[40]  C. M. Collis,et al.  Class 1 Integron Containing a New Gene Cassette, aadA10, Associated with Tn1404 from R151 , 2002, Antimicrobial Agents and Chemotherapy.

[41]  P. Nordmann,et al.  Molecular Characterization of a Novel Class 1 Integron Containing blaGES-1 and a Fused Product of aac(3)-Ib/aac(6")-Ib" Gene Cassettes in Pseudomonas aeruginosa , 2002, Antimicrobial Agents and Chemotherapy.

[42]  S. Kocsi,et al.  Correlation between aminoglycoside resistance profiles and DNA hybridization of clinical isolates , 1991, Antimicrobial Agents and Chemotherapy.

[43]  D. Sherman,et al.  Characterization of a Pseudomonas aeruginosa Efflux Pump Contributing to Aminoglycoside Impermeability , 1999, Antimicrobial Agents and Chemotherapy.

[44]  P. Strike,et al.  A pathway for the evolution of the plasmid NTP16 involving the novel kanamycin resistance transposon Tn4352. , 1987, Plasmid.

[45]  A. Allsop.  New antibiotic discovery, novel screens, novel targets and impact of microbial genomics. , 1998, Current opinion in microbiology.

[46]  H. Chung,et al.  Comparison of aminoglycoside resistance patterns in Japan, Formosa, and Korea, Chile, and the United States , 1985, Antimicrobial Agents and Chemotherapy.

[47]  Ronald N. Jones,et al.  Clinical prevalence, antimicrobial susceptibility, and geographic resistance patterns of enterococci: results from the SENTRY Antimicrobial Surveillance Program, 1997-1999. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[48]  L. Kotra,et al.  Aminoglycoside Antibiotics: Structures and Mechanisms of Action , 2001 .

[49]  A. Tärnvik,et al.  Susceptibility to beta-lactam antibiotics and gentamicin of gram-negative bacilli isolated from hospitalized patients: a Swedish multicenter study. , 1988, Scandinavian journal of infectious diseases.

[50]  A. Osborn,et al.  R391: a Conjugative Integrating Mosaic Comprised of Phage, Plasmid, and Transposon Elements , 2002, Journal of bacteriology.

[51]  Michael H. Miller,et al.  Gentamicin Uptake in Wild-Type and Aminoglycoside-Resistant Small-Colony Mutants of Staphylococcus aureus , 1980, Antimicrobial Agents and Chemotherapy.

[52]  A. Berghuis,et al.  Protein kinase inhibitors and antibiotic resistance. , 2002, Pharmacology & therapeutics.

[53]  T Lambert,et al.  A spontaneous point mutation in the aac(6')-Ib' gene results in altered substrate specificity of aminoglycoside 6'-N-acetyltransferase of a Pseudomonas fluorescens strain. , 1994, FEMS microbiology letters.

[54]  A. Caprioli,et al.  Detection and characterization of class 1 integrons in enterohemorrhagic Escherichia coli. , 2002, Microbial drug resistance.

[55]  J. Duval,et al.  Resistance of enterococci to aminoglycosides and glycopeptides. , 1992, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[56]  J. Kalinowski,et al.  The 51,409-bp R-plasmid pTP10 from the multiresistant clinical isolate Corynebacterium striatum M82B is composed of DNA segments initially identified in soil bacteria and in plant, animal, and human pathogens , 2000, Molecular and General Genetics MGG.

[57]  L. Brakier-Gingras,et al.  Cross-linking of streptomycin to the 16S ribosomal RNA of Escherichia coli. , 1987, Biochemistry.

[58]  R. Moellering,et al.  Studies on antibiotic syngerism against enterococci. II. Effect of various antibiotics on the uptake of 14 C-labeled streptomycin by enterococci. , 1971, The Journal of clinical investigation.

[59]  J. Ruiloba.  [Antimicrobial combinations]. , 1972, Gaceta medica de Mexico.

[60]  L. Dixon,et al.  An analysis of the complete nucleotide sequence of the Haemophilus ducreyi broad-host-range plasmid pLS88. , 1994, Plasmid.

[61]  Richard A. Moore,et al.  Efflux-Mediated Aminoglycoside and Macrolide Resistance in Burkholderia pseudomallei , 1999, Antimicrobial Agents and Chemotherapy.

[62]  N. Legakis,et al.  Survey of aminoglycoside resistance patterns. , 1986, Chemioterapia : international journal of the Mediterranean Society of Chemotherapy.

[63]  J. Karlowsky,et al.  Postantibiotic effect in Pseudomonas aeruginosa following single and multiple aminoglycoside exposures in vitro. , 1994, The Journal of antimicrobial chemotherapy.

[64]  P. Heinzel,et al.  A second streptomycin resistance gene from Streptomyces griseus codes for streptomycin-3″-phosphotransferase , 1988, Archives of Microbiology.

[65]  John W. Beaber,et al.  Genomic and Functional Analyses of SXT, an Integrating Antibiotic Resistance Gene Transfer Element Derived from Vibrio cholerae , 2002, Journal of bacteriology.

[66]  K. Shaw,et al.  The most frequently occurring aminoglycoside resistance mechanisms--combined results of surveys in eight regions of the world. The Aminoglycoside Resistance Study Groups. , 1995, Journal of chemotherapy.

[67]  P. Nordmann,et al.  Extended-spectrum beta-lactamase-producing strain of Acinetobacter baumannii isolated from a patient in France. , 1999, The Journal of antimicrobial chemotherapy.

[68]  G. Eliopoulos,et al.  Ribosomal Resistance of Clinical Enterococcal Isolates to Streptomycin , 1984, Antimicrobial Agents and Chemotherapy.

[69]  W. S. Champney,et al.  30S Ribosomal Subunit Assembly Is a Target for Inhibition by Aminoglycosides in Escherichia coli , 2002, Antimicrobial Agents and Chemotherapy.

[70]  European Study Group on Antibiotic Resistance.  In vitro susceptibility to aminoglycoside antibiotics in blood and urine isolates consecutively collected in twenty-nine European laboratories , 2005, European Journal of Clinical Microbiology.

[71]  Tetsuya Hayashi,et al.  Complete Nucleotide Sequence of Plasmid Rts1: Implications for Evolution of Large Plasmid Genomes , 2002, Journal of bacteriology.

[72]  Weber.  Antimicrobial Therapy and Vaccines , 2002 .

[73]  M. Raviglione,et al.  Drug-resistant tuberculosis: review of the worldwide situation and the WHO/IUATLD Global Surveillance Project. International Union Against Tuberculosis and Lung Disease. , 1997, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[74]  D. Livermore,et al.  In Vitro Activities of Antibiotics Alone and in Combination against Brucella melitensis at Neutral and Acidic pHs , 1999, Antimicrobial Agents and Chemotherapy.

[75]  S. Magnet,et al.  Resistance-Nodulation-Cell Division-Type Efflux Pump Involved in Aminoglycoside Resistance in Acinetobacter baumannii Strain BM4454 , 2001, Antimicrobial Agents and Chemotherapy.

[76]  P. Sparling,et al.  Ribosomal Resistance to Streptomycin and Spectinomycin in Neisseria gonorrhoeae , 1974, Journal of bacteriology.

[77]  Chantal D. Larose,et al.  PCR mapping of integrons reveals several novel combinations of resistance genes , 1995, Antimicrobial agents and chemotherapy.

[78]  B. D. Davis.  Mechanism of bactericidal action of aminoglycosides , 1987, Microbiological reviews.

[79]  P. Rather,et al.  Activation of the 2′- N -Acetyltransferase Gene [aac(2′)-Ia] inProvidencia stuartii by an Interaction of AarP with the Promoter Region , 1999, Antimicrobial Agents and Chemotherapy.

[80]  H. Sugisaki,et al.  Nucleotide sequence of the kanamycin resistance transposon Tn903. , 1981, Journal of molecular biology.

[81]  Arjun Srinivasan,et al.  Vancomycin Resistance in Staphylococci , 2002, Clinical Microbiology Reviews.

[82]  K. Bush,et al.  How β-Lactamases Have Driven Pharmaceutical Drug Discovery , 1998 .

[83]  G. Vovis,et al.  Genomics and Antimicrobial Drug Discovery , 1999, Antimicrobial Agents and Chemotherapy.

[84]  Overexpression and Characterization of the Chromosomal Aminoglycoside 2′-N-Acetyltransferase ofProvidencia stuartii , 2001, Antimicrobial Agents and Chemotherapy.

[85]  M. Levison,et al.  Postantibiotic effect of penicillin plus gentamicin versus Enterococcus faecalis in vitro and in vivo , 1989, Antimicrobial Agents and Chemotherapy.

[86]  S. Schwarz,et al.  Nucleotide sequence and organization of plasmid pMVSCS1 from Mannheimia varigena: identification of a multiresistance gene cluster. , 2002, The Journal of antimicrobial chemotherapy.

[87]  G. Drusano.  Role of pharmacokinetics in the outcome of infections , 1988, Antimicrobial Agents and Chemotherapy.

[88]  F. K. Gould,et al.  Role of aminoglycosides in the treatment of bacterial endocarditis. , 2002, The Journal of antimicrobial chemotherapy.

[89]  G. Sundin.  Examination of base pair variants of the strA-strB streptomycin resistance genes from bacterial pathogens of humans, animals and plants. , 2000, The Journal of antimicrobial chemotherapy.

[90]  F. Ratjen,et al.  Effect of inhaled tobramycin on early Pseudomonas aeruginosa colonisation in patients with cystic fibrosis , 2001, The Lancet.

[91]  H. Sørum,et al.  Functional Tn5393-Like Transposon in the R Plasmid pRAS2 from the Fish Pathogen Aeromonas salmonicida subspecies salmonicida Isolated in Norway , 2000, Applied and Environmental Microbiology.

[92]  D. Shlaes,et al.  The most frequent aminoglycoside resistance mechanisms--changes with time and geographic area: a reflection of aminoglycoside usage patterns? Aminoglycoside Resistance Study Groups. , 1997, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[93]  J. Lemeland,et al.  In Vitro Synergistic Effects of Double and Triple Combinations of β-Lactams, Vancomycin, and Netilmicin against Methicillin-Resistant Staphylococcus aureusStrains , 2000, Antimicrobial Agents and Chemotherapy.

[94]  K. Shaw,et al.  The changing nature of aminoglycoside resistance mechanisms and the role of isepamicin--a new broad-spectrum aminoglycoside. The Aminoglycoside Resistance Study Groups. , 1995, Journal of chemotherapy.

[95]  M. Sugiyama,et al.  IS431mec-mediated integration of a bleomycin-resistance gene into the chromosome of a methicillin-resistant Staphylococcus aureus strain isolated in Japan , 1996, Applied Microbiology and Biotechnology.

[96]  Ellen Murphy,et al.  Genomics in anti-infective drug discovery--getting to endgame. , 2002, Current pharmaceutical design.

[97]  H. Umezawa,et al.  Syntheses of 6'-N-methyl-kanamycin and 3',4'-dideoxy-6'-N-methylkanamycin B active against resistant strains having 6'-N-acetylating enzymes. , 1972, The Journal of antibiotics.

[98]  R. Allmansberger,et al.  Genes for gentamicin-(3)-N-acetyl-transferases III and IV , 2004, Molecular and General Genetics MGG.

[99]  K. E. Price,et al.  Epidemiological studies of aminoglycoside resistance in the U.S.A. , 1981, The Journal of antimicrobial chemotherapy.

[100]  A. Percival,et al.  Clinical and laboratory studies with carbenicillin. A new penicillin active against Pseudomonas pyocyanea. , 1967, Lancet.

[101]  R. B. Henschke,et al.  Nucleotide sequence analysis of 2″‐aminoglycoside nucleotidyl‐transferase ANT(2″) from Tn4000: its relationship with AAD(3″) and impact on Tn21 evolution , 1988, Molecular microbiology.

[102]  D. Vapnek,et al.  Nucleotide sequence analysis of a gene encoding a streptomycin/spectinomycin adenylyltransferase. , 1985, Plasmid.

[103]  T. Kato,et al.  Combined effects of meropenem and aminoglycosides on Pseudomonas aeruginosa in vitro. , 2000, The Journal of antimicrobial chemotherapy.

[104]  E. Cundliffe.  How antibiotic-producing organisms avoid suicide. , 1989, Annual review of microbiology.

[105]  R. Moellering,et al.  Antimicrobial-drug resistance. , 1996, The New England journal of medicine.

[106]  A. Quittner,et al.  Effects of tobramycin solution for inhalation on global ratings of quality of life in patients with cystic fibrosis and Pseudomonas aeruginosa infection * † , 2002, Pediatric pulmonology.

[107]  R. Hedges,et al.  Resistance to apramycin in Escherichia coli isolated from animals: detection of a novel aminoglycoside-modifying enzyme. , 1984, Journal of general microbiology.

[108]  S. Mobashery,et al.  Resolving the antibiotic paradox: progress in understanding drug resistance and development of new antibiotics. , 1998 .

[109]  F. Tenover,et al.  Detection of a Streptomycin/Spectinomycin Adenylyltransferase Gene (aadA) in Enterococcus faecalis , 1999, Antimicrobial Agents and Chemotherapy.

[110]  I. Chopra,et al.  Evidence for mutation to streptomycin resistance in clinical strains of Staphylococcus aureus. , 1972, Journal of general microbiology.

[111]  H. Sader,et al.  In vitro antimicrobial activity of the aminoglycoside arbekacin tested against oxacillin-resistant Staphylococcus aureus isolated in Brazilian hospitals. , 2001, The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases.

[112]  L. Kotra,et al.  Aminoglycosides: Perspectives on Mechanisms of Action and Resistance and Strategies to Counter Resistance , 2000, Antimicrobial Agents and Chemotherapy.

[113]  J. Puglisi,et al.  Structural origins of gentamicin antibiotic action , 1998, The EMBO journal.

[114]  Neville Firth,et al.  Complete Nucleotide Sequence of pSK41: Evolution of Staphylococcal Conjugative Multiresistance Plasmids , 1998, Journal of bacteriology.

[115]  M. Delmée,et al.  COMPARATIVE IN VITRO ACTIVITY OF ISEPAMICIN AND OTHER ANTIBIOTICS AGAINST GRAM-NEGATIVE BACILLI FROM INTENSIVE CARE UNITS (ICU) IN BELGIUM , 2001, Acta clinica Belgica.

[116]  P. Rather,et al.  Analysis of the aac(3)-VIa gene encoding a novel 3-N-acetyltransferase , 1993, Antimicrobial Agents and Chemotherapy.

[117]  P. Gangadharam,et al.  Therapy of Mycobacterium avium complex infections in beige mice with streptomycin encapsulated in sterically stabilized liposomes , 1995, Antimicrobial agents and chemotherapy.

[118]  S. Mobashery,et al.  Aminoglycoside-modifying enzymes: mechanisms of catalytic processes and inhibition. , 2001, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.

[119]  P. D. Cam,et al.  Cholera in Vietnam: Changes in Genotypes and Emergence of Class I Integrons Containing Aminoglycoside Resistance Gene Cassettes in Vibrio cholerae O1 Strains Isolated from 1979 to 1996 , 1999, Journal of Clinical Microbiology.

[120]  P. Rather,et al.  The chromosomal 2'-N-acetyltransferase of Providencia stuartii: physiological functions and genetic regulation. , 1999, Frontiers in bioscience : a journal and virtual library.

[121]  M. Ehrenberg,et al.  Dissociation rates of peptidyl‐tRNA from the P‐site of E.coli ribosomes. , 1996, The EMBO journal.

[122]  L. Ng,et al.  Genetic characterization of kanamycin resistance in Campylobacter coli. , 1988, Annales de l'Institut Pasteur. Microbiology.

[123]  F. Schluenzen,et al.  Structure of Functionally Activated Small Ribosomal Subunit at 3.3 Å Resolution , 2000, Cell.

[124]  Y. Nakamura,et al.  Complete genome sequence of the alkaliphilic bacterium Bacillus halodurans and genomic sequence comparison with Bacillus subtilis. , 2000, Nucleic acids research.

[125]  I. Phillips.  AMINOGLYCOSIDES , 1982, The Lancet.

[126]  A. Clarke,et al.  The role of O-acetylation in the metabolism of peptidoglycan in Providencia stuartii. , 1996, Microbial drug resistance.

[127]  G. Jacoby,et al.  Appearance of amikacin and tobramycin resistance due to 4'-aminoglycoside nucleotidyltransferase [ANT(4')-II] in gram-negative pathogens , 1990, Antimicrobial Agents and Chemotherapy.

[128]  M. Fling,et al.  Nucleotide sequence of the transposon Tn7 gene encoding an aminoglycoside-modifying enzyme, 3"(9)-O-nucleotidyltransferase. , 1985, Nucleic acids research.

[129]  E. Murphy.  Nucleotide sequence of a spectinomycin adenyltransferase AAD(9) determinant from Staphylococcus aureus and its relationship to AAD(3″) (9) , 2004, Molecular and General Genetics MGG.

[130]  M. Syvanen,et al.  Evolved neomycin phosphotransferase from an isolate of Klebsiella pneumoniae , 1991, Molecular Microbiology.

[131]  Robert M. Sweet,et al.  Structure of an Enzyme Required for Aminoglycoside Antibiotic Resistance Reveals Homology to Eukaryotic Protein Kinases , 1997, Cell.

[132]  V. Lorian.  Antibiotics in laboratory medicine , 2005 .

[133]  D. Hartung,et al.  Combination effect of SCE-2787 and cefepime with aminoglycosides on nosocomial gram-negative bacteria , 1991, Infection.

[134]  L. Young,et al.  1997 guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever. Infectious Diseases Society of America. , 1997, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[135]  S. Signorelli.  [Treatment of human brucellosis]. , 1951, Revista medica de Cordoba.

[136]  S. Mobashery,et al.  The use of neamine as a molecular template: inactivation of bacterial antibiotic resistance enzyme aminoglycoside 3'-phosphotransferase type IIa. , 1998, Bioorganic & medicinal chemistry letters.

[137]  R. Venezia,et al.  The resistance and integrase genes of pACM1, a conjugative multiple-resistance plasmid, from Klebsiella oxytoca. , 1997, Plasmid.

[138]  Ronald N. Jones,et al.  Characterization of Pseudomonas aeruginosa isolates: occurrence rates, antimicrobial susceptibility patterns, and molecular typing in the global SENTRY Antimicrobial Surveillance Program, 1997-1999. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[139]  J. Staneck,et al.  Clinical trial of the efficacy and safety of ticarcillin and clavulanic acid , 1985, Antimicrobial Agents and Chemotherapy.

[140]  J. Solera,et al.  Azithromycin and gentamicin therapy for the treatment of humans with brucellosis. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[141]  C. Herbert,et al.  Sequence and interspecies transfer of an aminoglycoside phosphotransferase gene (APH) of Bacillus circulans. Self-defence mechanism in antibiotic-producing organisms. , 1986, The Biochemical journal.

[142]  J. Duval,et al.  Characterization of the chromosomal aac(6')-Ii gene specific for Enterococcus faecium , 1993, Antimicrobial Agents and Chemotherapy.

[143]  J. Shenep,et al.  Guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever. , 1991, The Journal of infectious diseases.

[144]  J. Chow.  Aminoglycoside resistance in enterococci. , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[145]  W. Craig,et al.  Killing and regrowth of bacteria in vitro: a review. , 1990, Scandinavian journal of infectious diseases. Supplementum.

[146]  E. J. Young,et al.  An overview of human brucellosis. , 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[147]  S. Calderwood,et al.  Resistance to antibiotic synergism in Streptococcus faecalis: further studies with amikacin and with a new amikacin derivative, 4'-deoxy, 6'-N-methylamikacin , 1981, Antimicrobial Agents and Chemotherapy.

[148]  L. Kotra,et al.  From genes to sequences to antibiotics: prospects for future developments from microbial genomics. , 2000, Microbes and infection.

[149]  P. Courvalin,et al.  Characterization of Acinetobacter haemolyticus aac(6')-Ig gene encoding an aminoglycoside 6'-N-acetyltransferase which modifies amikacin , 1993, Antimicrobial Agents and Chemotherapy.

[150]  R. Moss.  Administration of aerosolized antibiotics in cystic fibrosis patients. , 2001, Chest.

[151]  L. E. Bryan,et al.  Mechanism of Aminoglycoside Antibiotic Resistance in Anaerobic Bacteria: Clostridium perfringens and Bacteroides fragilis , 1979, Antimicrobial Agents and Chemotherapy.

[152]  P. Courvalin,et al.  Nucleotide sequence analysis of the gene specifying the bifunctional 6'-aminoglycoside acetyltransferase 2"-aminoglycoside phosphotransferase enzyme in Streptococcus faecalis and identification and cloning of gene regions specifying the two activities , 1986, Journal of bacteriology.

[153]  Ronald N. Jones,et al.  Bacterial Pathogens Isolated from Patients with Bloodstream Infection: Frequencies of Occurrence and Antimicrobial Susceptibility Patterns from the SENTRY Antimicrobial Surveillance Program (United States and Canada, 1997) , 1998, Antimicrobial Agents and Chemotherapy.

[154]  A Yonath,et al.  Structure of functionally activated small ribosomal subunit at 3.3 angstroms resolution. , 2000, Cell.

[155]  R. Mattaliano,et al.  Nucleotide sequence of the hygromycin B phosphotransferase gene from Streptomyces hygroscopicus. , 1986, Nucleic acids research.

[156]  Chi-Huey Wong,et al.  Design of Bifunctional Antibiotics that Target Bacterial rRNA and Inhibit Resistance-Causing Enzymes , 2000 .

[157]  P. White,et al.  Integrons and Gene Cassettes in theEnterobacteriaceae , 2001, Antimicrobial Agents and Chemotherapy.

[158]  H. Nikaido,et al.  Involvement of an Active Efflux System in the Natural Resistance of Pseudomonas aeruginosa to Aminoglycosides , 1999, Antimicrobial Agents and Chemotherapy.

[159]  D. Leigh,et al.  Augmentin (amoxycillin and clavulanic acid) therapy in complicated infections due to beta-lactamase producing bacteria. , 1981, The Journal of antimicrobial chemotherapy.

[160]  D. Friend,et al.  Efficacies of liposome-encapsulated streptomycin and ciprofloxacin against Mycobacterium avium-M. intracellulare complex infections in human peripheral blood monocyte/macrophages , 1992, Antimicrobial Agents and Chemotherapy.

[161]  Teruyo Ito,et al.  Cloning and Nucleotide Sequence Determination of the Entire mec DNA of Pre-Methicillin-Resistant Staphylococcus aureus N315 , 1999, Antimicrobial Agents and Chemotherapy.

[162]  W. Fitzsimmons,et al.  Pharmacokinetics and in vivo activity of liposome-encapsulated gentamicin , 1990, Antimicrobial Agents and Chemotherapy.

[163]  L. Briceland,et al.  Single Daily Dosing of Aminoglycosides , 1995, Pharmacotherapy.

[164]  K. Shaw,et al.  Resistance to aminoglycoside antibiotics in gram-negative bacilli and staphylococci isolated from blood. Report from a European collaborative study. The ESGAR Study Group (European Study Group on Antibiotic Resistance). , 1990, The Journal of antimicrobial chemotherapy.

[165]  W. Craig,et al.  Pharmacodynamic properties of antibiotics: application to drug monitoring and dosage regimen design. , 1990, Infection control and hospital epidemiology.

[166]  S. Gillespie,et al.  Evolution of Drug Resistance in Mycobacterium tuberculosis: Clinical and Molecular Perspective , 2002, Antimicrobial Agents and Chemotherapy.

[167]  R. Woodgate,et al.  Molecular Analysis of Antibiotic Resistance Gene Clusters in Vibrio cholerae O139 and O1 SXT Constins , 2001, Antimicrobial Agents and Chemotherapy.

[168]  J. Davies,et al.  Plasmid-encoded hygromycin B resistance: the sequence of hygromycin B phosphotransferase gene and its expression in Escherichia coli and Saccharomyces cerevisiae. , 1983, Gene.

[169]  M. Zervos,et al.  Detection of the High-Level Aminoglycoside Resistance Gene aph(2")-Ib in Enterococcus faecium , 2000, Antimicrobial Agents and Chemotherapy.

[170]  H. Nikaido,et al.  AcrD of Escherichia coli Is an Aminoglycoside Efflux Pump , 2000, Journal of bacteriology.

[171]  E. J. Young,et al.  Antimicrobial susceptibility of clinical isolates of Brucella. , 1986, Diagnostic microbiology and infectious disease.

[172]  J. Spivey.  The postantibiotic effect. , 1992, Clinical pharmacy.

[173]  G. Wright,et al.  Aminoglycoside antibiotics. Structures, functions, and resistance. , 1998, Advances in experimental medicine and biology.

[174]  J. Davies,et al.  Isolation and characterisation of an aminoglycoside phosphotransferase from neomycin-producing Micromonospora chalcea; comparison with that of Streptomyces fradiae and other producers of 4,6-disubstituted 2-deoxystreptamine antibiotics. , 1991, The Journal of antibiotics.

[175]  A. Carattoli,et al.  Antibiotic Resistance Conferred by a Conjugative Plasmid and a Class I Integron in Vibrio cholerae O1 El Tor Strains Isolated in Albania and Italy , 1999, Antimicrobial Agents and Chemotherapy.

[176]  Sande Ma,et al.  Nafcillin-gentamicin synergism in experimental staphylococcal endocarditis. , 1976 .

[177]  J. Hamilton-miller,et al.  Activity of the semi-synthetic kanamycin B derivative, arbekacin against methicillin-resistant Staphylococcus aureus. , 1995, The Journal of antimicrobial chemotherapy.

[178]  M. Ouellette,et al.  Acquisition by a Campylobacter-like strain of aphA-1, a kanamycin resistance determinant from members of the family Enterobacteriaceae , 1987, Antimicrobial Agents and Chemotherapy.

[179]  S. Carlson,et al.  Relative Distribution and Conservation of Genes Encoding Aminoglycoside-Modifying Enzymes in Salmonella enterica Serotype Typhimurium Phage Type DT104 , 2001, Applied and Environmental Microbiology.

[180]  A. Clarke,et al.  Characterization of gentamicin 2'-N-acetyltransferase from Providencia stuartii: its use of peptidoglycan metabolites for acetylation of both aminoglycosides and peptidoglycan , 1997, Journal of bacteriology.

[181]  G. Harding,et al.  The Postantibiotic Effect: A Review of in Vitro and in Vivo Data , 1991, DICP : the annals of pharmacotherapy.

[182]  Harry F. Noller,et al.  Interaction of antibiotics with functional sites in 16S ribosomal RNA , 1987, Nature.

[183]  P. McDonald,et al.  Persistent effect of antibiotics on Staphylococcus aureus after exposure for limited periods of time. , 1977, The Journal of infectious diseases.

[184]  M. Zervos,et al.  In-vitro activity of arbekacin alone and in combination with vancomycin against gentamicin- and methicillin-resistant Staphylococcus aureus. , 2000, Diagnostic microbiology and infectious disease.

[185]  P. O'Hara,et al.  Development of a DNA probe from the deoxyribonucleotide sequence of a 3-N-aminoglycoside acetyltransferase [AAC(3)-I] resistance gene , 1989, Antimicrobial Agents and Chemotherapy.

[186]  P. Courvalin,et al.  Dispersal in Campylobacter spp. of aphA-3, a kanamycin resistance determinant from gram-positive cocci , 1988, Antimicrobial Agents and Chemotherapy.

[187]  P. Trieu-Cuot,et al.  Nucleotide sequence of the Streptococcus faecalis plasmid gene encoding the 3'5"-aminoglycoside phosphotransferase type III. , 1983, Gene.

[188]  F. Tenover,et al.  Detection of two different kanamycin resistance genes in naturally occurring isolates of Campylobacter jejuni and Campylobacter coli , 1988, Antimicrobial Agents and Chemotherapy.

[189]  T. Ida,et al.  Antimicrobial activity of arbekacin, a new aminoglycoside antibiotic, against methicillin-resistant Staphylococcus aureus. , 1994, Drugs under experimental and clinical research.

[190]  N. Barg.  Construction of a probe for the aminoglycoside 3-V-acetyltransferase gene and detection of the gene among endemic clinical isolates , 1988, Antimicrobial Agents and Chemotherapy.

[191]  C. Schaffner,et al.  Cloning and characterization of a 3-N-aminoglycoside acetyltransferase gene, aac(3)-Ib, from Pseudomonas aeruginosa , 1995, Antimicrobial agents and chemotherapy.

[192]  D. Northrop,et al.  Alternative substrate and inhibition kinetics of aminoglycoside nucleotidyltransferase 2''-I in support of a Theorell-Chance kinetic mechanism. , 1988, Biochemistry.

[193]  J. Puglisi,et al.  Paromomycin binding induces a local conformational change in the A-site of 16 S rRNA. , 1998, Journal of molecular biology.

[194]  J. Prescott,et al.  The use of liposomally-entrapped gentamicin in the treatment of bovine Staphylococcus aureus mastitis. , 1988, Canadian journal of veterinary research = Revue canadienne de recherche veterinaire.

[195]  L. Brakier-Gingras,et al.  A mutation in the 530 loop of Escherichia coli 16S ribosomal RNA causes resistance to streptomycin. , 1988, Nucleic acids research.

[196]  J. Verhoef,et al.  Prevalence of Aminoglycoside Resistance in 20 European University Hospitals Participating in the European SENTRY Antimicrobial Surveillance Programme , 1999, European Journal of Clinical Microbiology and Infectious Diseases.

[197]  P. Nordmann,et al.  Molecular Characterization of OXA-20, a Novel Class D β-Lactamase, and Its Integron from Pseudomonas aeruginosa , 1998, Antimicrobial Agents and Chemotherapy.

[198]  A. Jones,et al.  Nucleotide sequence analysis of a transposon (Tn5393) carrying streptomycin resistance genes in Erwinia amylovora and other gram-negative bacteria , 1993, Journal of bacteriology.

[199]  J. Hopfield.  Kinetic proofreading: a new mechanism for reducing errors in biosynthetic processes requiring high specificity. , 1974, Proceedings of the National Academy of Sciences of the United States of America.

[200]  J. Blanchard,et al.  Overexpression and Mechanistic Analysis of Chromosomally Encoded Aminoglycoside 2′-N-Acetyltransferase (AAC(2′)-Ic) fromMycobacterium tuberculosis * , 2001, The Journal of Biological Chemistry.

[201]  R. Hall,et al.  Nucleotide sequence of the AAD(2'') aminoglycoside adenylyltransferase determinant aadB. Evolutionary relationship of this region with those surrounding aadA in R538-1 and dhfrII in R388. , 1986, Nucleic acids research.

[202]  P. Rather,et al.  Nucleotide sequence analysis and DNA hybridization studies of the ant(4')-IIa gene from Pseudomonas aeruginosa , 1993, Antimicrobial Agents and Chemotherapy.

[203]  E. Begg,et al.  Comparison of gentamicin dosing regimens using an in-vitro model. , 1992, The Journal of antimicrobial chemotherapy.

[204]  R. Hancock.  Alterations in outer membrane permeability. , 1984, Annual review of microbiology.

[205]  F. Szoka,et al.  Effect of size and lipid composition on the pharmacokinetics of intravitreal liposomes. , 1987, Investigative ophthalmology & visual science.

[206]  B. Gicquel,et al.  Aminoglycoside 2′‐N‐acetyltransferase genes are universally present in mycobacteria: characterization of the aac(2 ′)‐Ic gene from Mycobacterium tuberculosis and the aac(2 ′)‐Id gene from Mycobacterium smegmatis , 1997, Molecular microbiology.

[207]  P. Courvalin,et al.  Dissemination of amikacin resistance gene aphA6 in Acinetobacter spp , 1990, Antimicrobial Agents and Chemotherapy.

[208]  R. Wallace,,et al.  A single 16S ribosomal RNA substitution is responsible for resistance to amikacin and other 2-deoxystreptamine aminoglycosides in Mycobacterium abscessus and Mycobacterium chelonae. , 1998, The Journal of infectious diseases.

[209]  H. Segal,et al.  Identification and characterization of an aadB gene cassette at a secondary site in a plasmid from Acinetobacter. , 1997, FEMS microbiology letters.

[210]  Hoshiko Shigeru,et al.  Nucleotide sequence of the ribostamycin phosphotransferase gene and of its control region in Streptomyces ribosidificus. , 1988 .

[211]  L. Bryan,et al.  Effects of Membrane-Energy Mutations and Cations on Streptomycin and Gentamicin Accumulation by Bacteria: a Model for Entry of Streptomycin and Gentamicin in Susceptible and Resistant Bacteria , 1977, Antimicrobial Agents and Chemotherapy.

[212]  M. Sande,et al.  Nafcillin-gentamicin synergism in experimental staphylococcal endocarditis. , 1976, The Journal of laboratory and clinical medicine.

[213]  D. Krogstad,et al.  Resistance to Six Aminoglycosidic Aminocyclitol Antibiotics Among Enterococci: Prevalence, Evolution, and Relationship to Synergism with Penicillin , 1977, Antimicrobial Agents and Chemotherapy.

[214]  V. Ramakrishnan,et al.  The Structural Basis for the Action of the Antibiotics Tetracycline, Pactamycin, and Hygromycin B on the 30S Ribosomal Subunit , 2000, Cell.

[215]  C. Sigmund,et al.  Antibiotic resistance mutations in 16S and 23S ribosomal RNA genes of Escherichia coli. , 1984, Nucleic acids research.

[216]  R. Bulger.  In-vitro activity of cephalothin/kanamycin and methicillin/kanamycin combinations against methicillin-resistant Staphylococcus aureus. , 1967, Lancet.

[217]  S. Lory,et al.  Complete genome sequence of Pseudomonas aeruginosa PAO1, an opportunistic pathogen , 2000, Nature.

[218]  B. Purnelle,et al.  Sequence of the Bacillus subtilis genome region in the vicinity of the lev operon reveals two new extracytoplasmic function RNA polymerase sigma factors SigV and SigZ. , 1997, Microbiology.

[219]  K. Shaw,et al.  Isolation, characterization, and DNA sequence analysis of an AAC(6')-II gene from Pseudomonas aeruginosa , 1989, Antimicrobial Agents and Chemotherapy.

[220]  L. de wit,et al.  Characterization of the 6'-N-aminoglycoside acetyltransferase gene aac(6')-Im [corrected] associated with a sulI-type integron , 1997, Antimicrobial agents and chemotherapy.

[221]  L. Young,et al.  GUIDELINES FROM THE INFECTIOUS DISEASES SOCIETY OF AMERICA 1997 Guidelines for the Use of Antimicrobial Agents in Neutropenic Patients with Unexplained Fever , 1997 .

[222]  H. Noller,et al.  Ribosomes and translation. , 1997, Annual review of biochemistry.

[223]  K. Keddy,et al.  Vibrio cholerae O1 outbreak isolates in Mozambique and South Africa in 1998 are multiple-drug resistant, contain the SXT element and the aadA2 gene located on class 1 integrons. , 2001, The Journal of antimicrobial chemotherapy.

[224]  R. Lenk,et al.  Treatment of Brucella canis and Brucella abortus in vitro and in vivo by stable plurilamellar vesicle-encapsulated aminoglycosides. , 1985, The Journal of infectious diseases.

[225]  W. Craig,et al.  Factors affecting duration of in-vivo postantibiotic effect for aminoglycosides against gram-negative bacilli. , 1991, The Journal of antimicrobial chemotherapy.

[226]  L. Kotra,et al.  Tethered bisubstrate derivatives as probes for mechanism and as inhibitors of aminoglycoside 3'-phosphotransferases. , 2000, The Journal of organic chemistry.

[227]  J. Puglisi,et al.  Sequence-specific recognition of the major groove of RNA by deoxystreptamine. , 2002, Biochemistry.

[228]  S. Mobashery,et al.  Resolving the Antibiotic Paradox , 1998, Advances in Experimental Medicine and Biology.

[229]  P. Nordmann,et al.  Molecular characterisation of In51, a class 1 integron containing a novel aminoglycoside adenylyltransferase gene cassette, aadA6, in Pseudomonas aeruginosa. , 1999, Biochimica et biophysica acta.

[230]  D. Nicolau,et al.  Once-daily dosing of aminoglycosides: review and recommendations for clinical practice. , 1997, The Journal of antimicrobial chemotherapy.

[231]  P. Miller,et al.  Bacterial uptake of aminoglycoside antibiotics. , 1987, Microbiological reviews.

[232]  M. Sande,et al.  Penicillin-netilmicin synergism against Streptococcus faecalis , 1978, Antimicrobial Agents and Chemotherapy.

[233]  T. Ida,et al.  Antagonism between Aminoglycosides and β-Lactams in a Methicillin-Resistant Staphylococcus aureus Isolate Involves Induction of an Aminoglycoside-Modifying Enzyme , 2002, Antimicrobial Agents and Chemotherapy.

[234]  D. Sandvang.  Novel Streptomycin and Spectinomycin Resistance Gene as a Gene Cassette within a Class 1 Integron Isolated from Escherichia coli , 2000, Antimicrobial Agents and Chemotherapy.

[235]  G. Eliopoulos,et al.  Antibiotic combinations: should they be tested? , 1988, Clinical Microbiology Reviews.

[236]  Jill K Thompson,et al.  Methylation of 16S ribosomal RNA and resistance to the aminoglycoside antibiotics gentamicin and kanamycin determined by DNA from the gentamicin-producer, Micromonospora purpurea , 2004, Molecular and General Genetics MGG.

[237]  T. Aoki,et al.  The Transposon‐Like Structure of IS26‐Tetracycllne, and Kanamycin Resistance Determinant Derived from Transferable R Plasmid of Fish Pathogen, Pasteurella piscicida , 1994, Microbiology and immunology.

[238]  G. Wright,et al.  Overexpression and characterization of the chromosomal aminoglycoside 6'-N-acetyltransferase from Enterococcus faecium , 1997, Antimicrobial agents and chemotherapy.

[239]  T. Eickhoff,et al.  Effects of Ampicillin-Amikacin and Ampicillin-Rifampin on Enterococci , 1976, Antimicrobial Agents and Chemotherapy.

[240]  J. Puglisi,et al.  Structure of the A Site of Escherichia coli 16S Ribosomal RNA Complexed with an Aminoglycoside Antibiotic , 1996, Science.

[241]  P. Rather,et al.  Cloning and DNA sequence analysis of an aac(3)-Vb gene from Serratia marcescens , 1992, Antimicrobial Agents and Chemotherapy.

[242]  J. Frean,et al.  In vitro activities of 14 antibiotics against 100 human isolates of Yersinia pestis from a southern African plague focus , 1996, Antimicrobial agents and chemotherapy.

[243]  D. Northrop,et al.  Substrate specificities and structure-activity relationships for the nucleotidylation of antibiotics catalyzed by aminoglycoside nucleotidyltransferase 2''-I. , 1988, Biochemistry.

[244]  S. Tsai,et al.  A novel gentamicin resistance gene in Enterococcus , 1997, Antimicrobial agents and chemotherapy.

[245]  D. Hollis,et al.  Antimicrobial susceptibility testing of Francisella tularensis with a modified Mueller-Hinton broth , 1985, Journal of clinical microbiology.

[246]  P. H. Roy,et al.  Characterization of In0 of Pseudomonas aeruginosa plasmid pVS1, an ancestor of integrons of multiresistance plasmids and transposons of gram-negative bacteria , 1992, Journal of bacteriology.

[247]  C. Torres,et al.  Bifunctional Enzyme 6′-N-Aminoglycoside Acetyltransferase-2"-O- Aminoglycoside Phosphotransferase in Lactobacillus and Pediococcus Isolates of Animal Origin , 2001, Journal of Clinical Microbiology.

[248]  R. Hütter,et al.  Characterisation of the hydroxystreptomycin phosphotransferase gene (sph) of Streptomyces glaucescens: Nucleotide sequence and promoter analysis , 1987, Molecular and General Genetics MGG.

[249]  J. Verhoef,et al.  The prevalence of aminoglycoside resistance and corresponding resistance genes in clinical isolates of staphylococci from 19 European hospitals. , 1999, The Journal of antimicrobial chemotherapy.

[250]  A. Forsgren,et al.  In vitro aminoglycoside resistance of gram-negative bacilli and staphylococci isolated from blood in Sweden 1980-1984. , 1986, Scandinavian journal of infectious diseases.

[251]  M. Ehrenberg,et al.  Dissociation rate of cognate peptidyl-tRNA from the A-site of hyper-accurate and error-prone ribosomes. , 1994, European journal of biochemistry.

[252]  W. Epstein,et al.  Role of the membrane potential in bacterial resistance to aminoglycoside antibiotics , 1981, Antimicrobial Agents and Chemotherapy.

[253]  C. Vonrhein,et al.  Structure of the 30S ribosomal subunit , 2000, Nature.

[254]  P. H. Roy,et al.  Presence of a Group II Intron in a Multiresistant Serratia marcescens Strain That Harbors Three Integrons and a Novel Gene Fusion , 2002, Antimicrobial Agents and Chemotherapy.

[255]  A E Dahlberg,et al.  A conformational switch in Escherichia coli 16S ribosomal RNA during decoding of messenger RNA. , 1997, Science.

[256]  J. Davies,et al.  Plasmid-determined resistance to antimicrobial agents. , 1978, Annual review of microbiology.

[257]  Y. Zhang,et al.  Intravitreal pharmacokinetics of liposome-encapsulated amikacin in a rabbit model. , 1993, Ophthalmology (Rochester, Minn.).

[258]  S. Ünal,et al.  The changing nature of aminoglycoside resistance mechanisms and prevalence of newly recognized resistance mechanisms in Turkey. , 2001, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[259]  W. Fitch,et al.  Evolution of antibiotic resistance genes: the DNA sequence of a kanamycin resistance gene from Staphylococcus aureus. , 1983, Molecular biology and evolution.

[260]  A. Ebert,et al.  Gene cluster for streptomycin biosynthesis in Streptomyces griseus: nucleotide sequence of three genes and analysis of transcriptional activity. , 1987, Nucleic acids research.

[261]  E. Scherzinger,et al.  Complete nucleotide sequence and gene organization of the broad-host-range plasmid RSF1010. , 1989, Gene.

[262]  John E. Bennett,et al.  Principles and practice of infectious diseases. Vols 1 and 2. , 1979 .

[263]  D. Shanson.  New guidelines for the antibiotic treatment of streptococcal, enterococcal and staphylococcal endocarditis. , 1998, The Journal of antimicrobial chemotherapy.

[264]  T. Tadakuma,et al.  Treatment of experimental salmonellosis in mice with streptomycin entrapped in liposomes , 1985, Antimicrobial Agents and Chemotherapy.

[265]  N. Kobayashi,et al.  Distribution of aminoglycoside resistance genes in recent clinical isolates of Enterococcus faecalis, Enterococcus faecium and Enterococcus avium , 2001, Epidemiology and Infection.

[266]  D. Reeves,et al.  AAC(1): a new aminoglycoside-acetylating enzyme modifying the Cl aminogroup of apramycin. , 1987, The Journal of antimicrobial chemotherapy.

[267]  Amita,et al.  Occurrence of Antibiotic Resistance Gene Cassettes aac(6′)-Ib, dfrA5, dfrA12, and ereA2 in Class I Integrons in Non-O1, Non-O139 Vibrio cholerae Strains in India , 2002, Antimicrobial Agents and Chemotherapy.

[268]  R. Owens,et al.  In vitro synergistic activities of tobramycin and selected beta-lactams against 75 gram-negative clinical isolates , 1997, Antimicrobial agents and chemotherapy.

[269]  P. Courvalin,et al.  Detection of apramycin resistant Enterobacteriaceae in hospital isolates. , 1989, FEMS microbiology letters.

[270]  R. Sutherland,et al.  Synergy Between Ticarcillin and Tobramycin Against Pseudomonas aeruginosa and Enterobacteriaceae In Vitro and In Vivo , 1977, Antimicrobial Agents and Chemotherapy.

[271]  A. Dashti,et al.  Detection of genes encoding aminoglycoside-modifying enzymes in staphylococci by polymerase chain reaction and dot blot hybridization. , 2000, International journal of antimicrobial agents.

[272]  M. Matsumura,et al.  Enzymatic and nucleotide sequence studies of a kanamycin-inactivating enzyme encoded by a plasmid from thermophilic bacilli in comparison with that encoded by plasmid pUB110 , 1984, Journal of bacteriology.

[273]  B. Khoobehi,et al.  Intravitreal liposome-encapsulated drugs: A preliminary human report , 2004, International Ophthalmology.

[274]  T. Calandra,et al.  Guidelines for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer , 2002 .

[275]  P. O'Hara,et al.  Nucleotide sequence of a novel kanamycin resistance gene, aphA-7, from Campylobacter jejuni and comparison to other kanamycin phosphotransferase genes. , 1989, Plasmid.

[276]  R. Moss.  Long-term benefits of inhaled tobramycin in adolescent patients with cystic fibrosis. , 2002, Chest.

[277]  A. Goffeau,et al.  Analysis of the chromosome sequence of the legume symbiont Sinorhizobium meliloti strain 1021 , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[278]  M. Ploy,et al.  Molecular Characterization of Integrons inAcinetobacter baumannii: Description of a Hybrid Class 2 Integron , 2000, Antimicrobial Agents and Chemotherapy.

[279]  Lakshmi P Kotra,et al.  Design of novel antibiotics that bind to the ribosomal acyltransfer site. , 2002, Journal of the American Chemical Society.

[280]  M. Zervos,et al.  Efficacy of Ampicillin plus Arbekacin in Experimental Rabbit Endocarditis Caused by an Enterococcus faecalis Strain with High-Level Gentamicin Resistance , 2000, Antimicrobial Agents and Chemotherapy.

[281]  J. Ninio.  Kinetic amplification of enzyme discrimination. , 1975, Biochimie.

[282]  J. Davies,et al.  Enzymatic Modification of Aminoglycoside Antibiotics: a New 3-N-Acetylating Enzyme from a Pseudomonas aeruginosa Isolate , 1976, Antimicrobial Agents and Chemotherapy.

[283]  G. Sundin,et al.  Dissemination of the strA‐strB streptomycin‐resistance genes among commensal and pathogenic bacteria from humans, animals, and plants , 1996, Molecular ecology.

[284]  W. Witte,et al.  Aminoglycoside-Streptothricin Resistance Gene Cluster aadE–sat4–aphA-3 Disseminated among Multiresistant Isolates of Enterococcus faecium , 2001, Antimicrobial Agents and Chemotherapy.

[285]  P. Gangadharam,et al.  Activity of free and liposome encapsulated streptomycin against Mycobacterium avium complex (MAC) inside peritoneal macrophages. , 1991, The Journal of antimicrobial chemotherapy.

[286]  J. Klastersky,et al.  Bacteriological and clinical activity of the ampicillin/gentamicin and cephalothin/gentamicin combinations , 1971, The American journal of the medical sciences.

[287]  P. Courvalin,et al.  Transferable amikacin resistance in Acinetobacter spp. due to a new type of 3'-aminoglycoside phosphotransferase , 1988, Antimicrobial Agents and Chemotherapy.

[288]  R. Ramphal.  1997 Guidelines for the Use of Antimicrobial Agents in Neutropenic Patients with Unexplained Fever , 1998 .

[289]  J. Altenbuchner,et al.  A spectinomyciin resistance determinant from the spectinomycin producerStreptomyces flavopersicus , 1997 .

[290]  B. Gicquel,et al.  Characterization of the chromosomal aminoglycoside 2'-N-acetyltransferase gene from Mycobacterium fortuitum , 1996, Antimicrobial agents and chemotherapy.

[291]  P. H. Roy,et al.  Characterization of the 6′-N-Aminoglycoside Acetyltransferase Geneaac(6′)-Iq from the Integron of a Natural Multiresistance Plasmid , 1998, Antimicrobial Agents and Chemotherapy.

[292]  G. Eliopoulos,et al.  Ribosomal resistance of clinical enterococcal to streptomycin isolates , 1984, Antimicrobial Agents and Chemotherapy.

[293]  J. Musser,et al.  Antimicrobial agent resistance in mycobacteria: molecular genetic insights , 1995, Clinical microbiology reviews.

[294]  D. Vapnek,et al.  Nucleotide sequence analysis of a gene encoding a streptomycin/spectinomycin adenyltransferase , 1985 .

[295]  V. Ramakrishnan,et al.  Functional insights from the structure of the 30S ribosomal subunit and its interactions with antibiotics , 2000, Nature.

[296]  L. Couch.  Treatment With tobramycin solution for inhalation in bronchiectasis patients with Pseudomonas aeruginosa. , 2001, Chest.

[297]  R. Moore,et al.  Clinical response to aminoglycoside therapy: importance of the ratio of peak concentration to minimal inhibitory concentration. , 1987, The Journal of infectious diseases.

[298]  L. Kotra,et al.  Aminoglycosides modified by resistance enzymes display diminished binding to the bacterial ribosomal aminoacyl-tRNA site. , 2002, Chemistry & biology.

[299]  M. Mulvey,et al.  Characterization of Variant Salmonella Genomic Island 1 Multidrug Resistance Regions from Serovars Typhimurium DT104 and Agona , 2002, Antimicrobial Agents and Chemotherapy.

[300]  A. Dalsgaard,et al.  Distribution and Content of Class 1 Integrons in Different Vibrio cholerae O-Serotype Strains Isolated in Thailand , 2000, Antimicrobial Agents and Chemotherapy.

[301]  K. Ubukata,et al.  Purification and characterization of aminoglycoside-modifying enzymes from Staphylococcus aureus and Staphylococcus epidermidis , 1984, Antimicrobial Agents and Chemotherapy.

[302]  P. Rather,et al.  Contribution of gentamicin 2'-N-acetyltransferase to the O acetylation of peptidoglycan in Providencia stuartii , 1995, Journal of bacteriology.

[303]  D. Raoult,et al.  Use of Aminoglycosides in Treatment of Infections Due to Intracellular Bacteria , 2001, Antimicrobial Agents and Chemotherapy.

[304]  V. Ramakrishnan,et al.  Crystal structure of the 30 S ribosomal subunit from Thermus thermophilus: structure of the proteins and their interactions with 16 S RNA. , 2002, Journal of molecular biology.

[305]  C. Carlier,et al.  Emergence of 4',4"-aminoglycoside nucleotidyltransferase in enterococci , 1990, Antimicrobial Agents and Chemotherapy.

[306]  W. Craig,et al.  Postantibiotic suppression of bacterial growth. , 1981, Reviews of infectious diseases.

[307]  P. Nordmann,et al.  Characterization of Class 1 Integrons from Pseudomonas aeruginosa That Contain the blaVIM-2Carbapenem-Hydrolyzing β-Lactamase Gene and of Two Novel Aminoglycoside Resistance Gene Cassettes , 2001, Antimicrobial Agents and Chemotherapy.

[308]  J. Davies,et al.  Enzymatic Modification of Aminoglycoside Antibiotics: a New 6′-N-Acetylating Enzyme from a Pseudomonas aeruginosa Isolate , 1976, Antimicrobial Agents and Chemotherapy.

[309]  J. Content,et al.  Nomenclature of Genes Encoding Aminoglycoside-Modifying Enzymes , 1998, Antimicrobial Agents and Chemotherapy.

[310]  C. Kurland,et al.  Streptomycin preferentially perturbs ribosomal proofreading , 2004, Molecular and General Genetics MGG.

[311]  G. Sundin,et al.  Ecological and genetic analysis of copper and streptomycin resistance in Pseudomonas syringae pv. syringae , 1993, Applied and environmental microbiology.

[312]  P. Rather,et al.  Genetic analysis of bacterial acetyltransferases: identification of amino acids determining the specificities of the aminoglycoside 6'-N-acetyltransferase Ib and IIa proteins , 1992, Journal of bacteriology.

[313]  J. Vliegenthart,et al.  Nucleotide sequence of the aacC3 gene, a gentamicin resistance determinant encoding aminoglycoside-(3)-N-acetyltransferase III expressed in Pseudomonas aeruginosa but not in Escherichia coli , 1991, Antimicrobial Agents and Chemotherapy.

[314]  J. Altenbuchner,et al.  A spectinomycin resistance determinant from the spectinomycin producer Streptomyces flavopersicus. , 1997, Microbiology.

[315]  S. Waksman,et al.  Effect of Streptomycin and Other Antibiotic Substances upon Mycobacterium tuberculosis and Related Organisms.∗,† , 1944 .

[316]  P. Courvalin,et al.  Aminoglycoside-modifying enzymes of Staphylococcus aureus; expression in Escherichia coli. , 1980, Gene.

[317]  Nucleotide sequence of the chromosomal gene coding for the aminoglycoside 6-adenylyltransferase from Bacillus subtilis Marburg 168. , 1989 .

[318]  C. Baxter,et al.  Liposome delivery of aminoglycosides in burn wounds. , 1992, Surgery, gynecology & obstetrics.

[319]  M. Ploy,et al.  Characterization of the Chromosomalaac(6′)-Iz Gene of Stenotrophomonas maltophilia , 1999, Antimicrobial Agents and Chemotherapy.

[320]  C. Carlier,et al.  Gene homogeneity for aminoglycoside-modifying enzymes in gram-positive cocci , 1990, Antimicrobial Agents and Chemotherapy.

[321]  P. Rather,et al.  Characterization and transcriptional regulation of the 2'-N-acetyltransferase gene from Providencia stuartii , 1993, Journal of bacteriology.

[322]  P. Courvalin,et al.  Characterization of the aac(6')-Ik gene of Acinetobacter sp. 6. , 1994, FEMS microbiology letters.

[323]  P. Rather,et al.  Characterization of the chromosomal aac(6')-Ic gene from Serratia marcescens , 1992, Antimicrobial Agents and Chemotherapy.

[324]  F. Schluenzen,et al.  Structure of Functionally Activated Small Ribosomal Subunit , 2000 .

[325]  M. Zervos,et al.  A New High-Level Gentamicin Resistance Gene,aph(2")-Id, in Enterococcus spp , 1998, Antimicrobial Agents and Chemotherapy.

[326]  J. H. Crosa,et al.  Genetic organization of antibiotic resistance genes (aac(6')-Ib, aadA, and oxa9) in the multiresistance transposon Tn1331. , 1993, Plasmid.

[327]  G. Wright,et al.  Kinetic Mechanism of Aminoglycoside Phosphotransferase Type IIIa , 1995, The Journal of Biological Chemistry.

[328]  F. Kayser,et al.  Sequence and characterization of a novel chromosomal aminoglycoside phosphotransferase gene, aph (3')-IIb, in Pseudomonas aeruginosa , 1996, Antimicrobial agents and chemotherapy.

[329]  C. Baxter,et al.  Liposome encapsulation: a method for enhancing the effectiveness of local antibiotics. , 1994, Surgery.

[330]  Y. Aoki.  Bactericidal activity of arbekacin against methicillin-resistant Staphylococcus aureus. Comparison with that of vancomycin. , 1994, The Japanese journal of antibiotics.

[331]  T. Steitz,et al.  The complete atomic structure of the large ribosomal subunit at 2.4 A resolution. , 2000, Science.

[332]  G. Sundin,et al.  Expression of the strA-strB streptomycin resistance genes in Pseudomonas syringae and Xanthomonas campestris and characterization of IS6100 in X. campestris , 1995, Applied and environmental microbiology.

[333]  T. Ida,et al.  Identification of Aminoglycoside-Modifying Enzymes by Susceptibility Testing: Epidemiology of Methicillin-Resistant Staphylococcus aureus in Japan , 2001, Journal of Clinical Microbiology.

[334]  Frank Schluenzen,et al.  High Resolution Structure of the Large Ribosomal Subunit from a Mesophilic Eubacterium , 2001, Cell.